Product Code: SR112023A6128
Abstract
Market Overview:
The global neurovascular devices market size reached US$ 2.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.9 Billion by 2028, exhibiting a growth rate (CAGR) of 5.9% during 2023-2028.
Neurovascular devices, also known as interventional neurology devices, are used to treat neurovascular disorders, such as ischemic stroke aneurysms, stenosis, arteriovenous malformation, and fistulas. They include embolic coils, liquid embolic agents, flow diversion devices, arterial stents, catheters, and guidewires. They allow physicians to gain endovascular access to the treatment areas in the brain and provide efficient treatment. As a result, they are gaining immense traction in the healthcare industry and are extensively used in the treatment and diagnosis of numerous peripheral and central nervous system disorders and ailments.
Neurovascular Devices Market Trends:
The growing global geriatric population, which is highly susceptible to acquiring these disorders, represents one of the key factors positively influencing the market. These disorders cause moderate to severe damage to the brain, resulting in conditions like strokes and cerebral hemorrhage. This, along with the rising lifestyle disorders, such as obesity, is catalyzing the demand for neurovascular devices across the globe. In addition, rapid urbanization, sedentary lifestyles, and stress are resulting in rising incidences of stroke, which, in turn, is increasing the need for neurovascular devices. The rising awareness among patients about the easy availability of treatment and reimbursement for neurological disorders is increasing the adoption of these devices and strengthening the growth of the market. Furthermore, technological advancements in neurovascular treatments and government initiatives to modernize healthcare infrastructure across the globe are offering a favorable market outlook. Additionally, various initiatives are being undertaken by governments of various countries to generate awareness among the general population about symptoms and measures to be taken in case of emergency and available treatment options. Moreover, rapid expansion of hospitals and surgical centers, ambulatory care centers, research laboratories, and academic institutes is increasing the requirement for neurovascular devices worldwide.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global neurovascular devices market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, application and end user.
Breakup by Product:
Cerebral Embolization and Aneurysm Coiling Devices
Embolic Coils
Flow Diverters
Liquid Embolic Agents
Cerebral Angioplasty and Stenting Systems
Carotid Artery Stents
Embolic Protection Devices
Neurothrombectomy Devices
Clot Retrieval Devices
Suction Devices
Vascular Snares
Support Devices
Micro Catheters
Micro Guidewires
Breakup by Application:
Ischemic Stroke
Aneurysm
Arteriovenous Malformation and Fistulas (AVM)
Stenosis
Others
Breakup by End User:
Hospitals
Ambulatory Surgical Centers
Clinics
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Acandis GmbH, Asahi Intecc Co. Ltd., Imperative Care Inc., Integer Holdings Corporation, Johnson & Johnson, Medtronic plc, MicroPort Scientific Corporation, Penumbra Inc., Perflow Medical Ltd., Rapid Medical, Stryker Corporation and Terumo Corporation.
Key Questions Answered in This Report
- 1. What was the size of the global neurovascular devices market in 2022?
- 2. What is the expected growth rate of the global neurovascular devices market during 2023-2028?
- 3. What are the key factors driving the global neurovascular devices market?
- 4. What has been the impact of COVID-19 on the global neurovascular devices market?
- 5. What is the breakup of the global neurovascular devices market based on the product?
- 6. What is the breakup of the global neurovascular devices market based on end user?
- 7. What are the key regions in the global neurovascular devices market?
- 8. Who are the key players/companies in the global neurovascular devices market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Neurovascular Devices Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Cerebral Embolization and Aneurysm Coiling Devices
- 6.1.1 Market Trends
- 6.1.2 Key Segments
- 6.1.2.1 Embolic Coils
- 6.1.2.2 Flow Diverters
- 6.1.2.3 Liquid Embolic Agents
- 6.1.3 Market Forecast
- 6.2 Cerebral Angioplasty and Stenting Systems
- 6.2.1 Market Trends
- 6.2.2 Key Segments
- 6.2.2.1 Carotid Artery Stents
- 6.2.2.2 Embolic Protection Devices
- 6.2.3 Market Forecast
- 6.3 Neurothrombectomy Devices
- 6.3.1 Market Trends
- 6.3.2 Key Segments
- 6.3.2.1 Clot Retrieval Devices
- 6.3.2.2 Suction Devices
- 6.3.2.3 Vascular Snares
- 6.3.3 Market Forecast
- 6.4 Support Devices
- 6.4.1 Market Trends
- 6.4.2 Key Segments
- 6.4.2.1 Micro Catheters
- 6.4.2.2 Micro Guidewires
- 6.4.3 Market Forecast
7 Market Breakup by Application
- 7.1 Ischemic Stroke
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Aneurysm
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Arteriovenous Malformation and Fistulas (AVM)
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Stenosis
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
8 Market Breakup by End User
- 8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Ambulatory Surgical Centers
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Clinics
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Acandis GmbH
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.2 Asahi Intecc Co. Ltd.
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.3 Imperative Care Inc.
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.4 Integer Holdings Corporation
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.5 Johnson & Johnson
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.6 Medtronic plc
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.7 MicroPort Scientific Corporation
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.8 Penumbra Inc.
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.9 Perflow Medical Ltd.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.10 Rapid Medical
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.11 Stryker Corporation
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.12 Terumo Corporation
- 14.3.12.1 Company Overview
- 14.3.12.2 Product Portfolio